未找到相关数据
A Phase Ib/II Study of Cancer Sternness Inhibitor Napabucasin (BB608) Combined with Weekly Paclitaxel in Advanced Triple Negative Breast Cancer.
被引：7
作者：
Becerra, Carlos
Braiteh, Fadi S.
Spira, Alexander I.
Langleben, Adrian
Panasci, Lawrence C.
Vukelja, Svetislava J.
Hinshaw, Ioana M.
Goodwin, Rachel Anne
Panella, Timothy J.
Edenfield, William Jeffery
Kossler, Kimiko
Hume, Stephanie
Li, Youzhi
Hitron, Matthew
Li, Chiang
机构：
[1] Texas Oncol Baylor Charles A Sammons Canc Ctr, Dallas, TX USA
[2] McKesson Specialty Hlth, US Oncol Network, The Woodlands, TX USA
[3] Virginia Canc Specialists Res Inst & Oncol Res, Fairfax, VA USA
[4] St Marys Hosp, Westmount, PQ, Canada
[5] Jewish Gen Hosp, Dept Oncol, Montreal, PQ, Canada
[6] Tyler Canc Ctr, US Oncol Res & Texas Oncol, Tyler, TX USA
[7] Rocky Mt Canc Ctr, Denver, CO USA
[8] Ottawa Hosp, Natl Canc Inst, Canada Clin Trials Grp, Ottawa, ON, Canada
[9] Univ Tennessee, Knoxville, TN USA
[10] Greenville Hosp Syst, Univ Med Ctr, Inst Translat Oncol Res, Greenville, SC USA
[11] Boston Biomed Inc, Cambridge, MA USA
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.1094
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1094
引用
收藏
页数：2
相关论文